جستجوی مقالات مرتبط با کلیدواژه « واکسن فلج اطفال » در نشریات گروه « دامپزشکی »

Poliomyelitis, an acute viral infectious disease caused by poliovirus, still remains a public health problem in developing countries. Despite the global effort to eradicate polio, continuing the polio immunization with a potent and safe vaccine is essential. For accurate vaccine evaluation, three types of cell lines including Hela, Hep2C and Vero were evaluated and compared using two methods of polio vaccine potency tests (micro & macro). For cells comparison, five different batches from polio vaccines were tested and to develop the test, five variables including viruses, cells, serum, media and Co2 were studied. For validation, the titer of which has been well established as a working reference preparation (WRP) was applied to control the accuracy and reproducibility of the testing system. Multiple comparisons were performed by analysis of variance (ANOVA) followed by Tokey HDS and LSD. No significant differences were found between the potency of vaccine batches and between macro and micro methods. Reduction in cells sensitivity and potency of vaccines was found with increasing passage number. Significant differences were found between the sensitivity of the cell lines. The highest potency of polio vaccines was obtained using Hela cells (GMT in macro and micro test = 10 6.35); Hep2C cells were afterwards (GMT in macro= 10 6.01 and in micro test= 10 5.94); Vero cells were lowest (GMT in macro= 10 5.78 and in micro test= 10 5.72). So, the sensitivity and accuracy of the potency test for evaluation of the polio vaccine in immunization program in Iran will be assured using the Hela cell line with low passage number in macro and micro methods.

Mycoplasma contaminants can be considered important not only for their roles as pathogens but also they may indicate that insufficient care has been taken during vaccine manufacture or quality control. The purpose of this study was to test the poliomyelitis vaccines for Mycoplasma by culture and polymerase chain reaction (PCR) methods. During 2008 to 2009, a total of 47 lots of oral poliomyelitis vaccines were produced by Razi Vaccine and Serum Research Institute (RVSRI) in Iran. They were evaluated by culture and PCR for detection of Mycoplasma. In culture method, PPLO broth and PPLO agar medium were used and in PCR method, universal primers that were selected from the region 16S ribosomal RNA of Mycoplasmas were applied. In culture method, no changes on pH and color in PPLO broth tubes and no colony growth on PPLO agar plates were seen. In PCR method, Mycoplasma DNA was not detected in any of the tested vaccines. It was concluded that the current culture method for Mycoplasmas is reliable to detect viable Mycoplasmas in oral poliomyelitis vaccines, but our results confirmed the use of PCR assay as an efficient supplement to culture method.